« Previous
Next »
International Journal of Cardiology
Volume 76, Issue 2
, Pages 257-258
, November 2000
Myocardial infarction after aspirin cessation in stable coronary artery disease patients
References
-
.
Collaborative overview of randomised trials of antiplatelets therapy. Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients.
Br Med J. 1994;308:81–106
- . Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. J Clin Invest. 1983;71:676–688
- . Platelet activation in unstable coronary disease. N Engl J Med. 1986;315:983–989
- . Platelet aggregation, coronary disease progression and future coronary events. Am J Cardiol. 1994;73:333–338
-
.
Rebound elevation in urinary thromboxane B2 and 6-keto-PFF1 alpha exacerbation alter aspirin withdrawal.
Prostaglandin Thromboxane Leukot Res. 1991;21A:157–160
PII: S0167-5273(00)00399-5
© 2000 Elsevier Science Ireland Ltd. All rights reserved.
« Previous
Next »
International Journal of Cardiology
Volume 76, Issue 2
, Pages 257-258
, November 2000
